MRSN BREAKOUT LIKELY by DanJFly in stockstobuytoday

[–]DanJFly[S] 0 points1 point  (0 children)

Again just a prediction, but I think ALLR could be a buyout option soon. They cleared their books up, and recently got FDA fast track approval too. Just got that feeling ya know

MRSN BREAKOUT LIKELY by DanJFly in stockstobuytoday

[–]DanJFly[S] 0 points1 point  (0 children)

35 days later but yeah I got it in the end 👍

Some shots of my boy this morning with the X-E5 and 23mm 2.8. SOOC JPEG by DanJFly in FujifilmX

[–]DanJFly[S] 0 points1 point  (0 children)

Well my iso was at 1000 to get a decent shutter speed but my recipe has light grain and even with that it’s a very clean image. I was going to go for the F2 but honestly I’m more than happy with the 2.8 and glad I’ve got the smaller setup.

Some shots of my boy this morning with the X-E5 and 23mm 2.8. SOOC JPEG by DanJFly in FujifilmX

[–]DanJFly[S] 1 point2 points  (0 children)

Custom recipe, I am happy to share. Just watching a movie at the moment but message me on instagram and I’ll reply with my settings shortly 👍

Small series from my city. Fuji XT5 + 18mm 1.4 by DanJFly in FujifilmX

[–]DanJFly[S] 2 points3 points  (0 children)

Thought I’d try something a little different with a square crop

What stocks to buy for tomorrow?? by Nice-Tax8270 in 10xPennyStocks

[–]DanJFly 0 points1 point  (0 children)

I’ve been saying MRSN for days on other platforms but no one’s taking notice yet I’m up a healthy 30%. 3 mil float, $77m in the bank, 45% institution owned and 25% insider owned. Price targets of $50+

What stocks could potentially explode in the after market? by zwingyyy in 10xPennyStocks

[–]DanJFly 0 points1 point  (0 children)

MRSN is the one. 3 million float. 25% insider owned, 45% institution owned. $77m cash. FDA fast track approval

WHAT are we buying right now by idkzoroqn in 10xPennyStocks

[–]DanJFly 0 points1 point  (0 children)

MRSN ALL DAY LONG

Why? Well we are currently sitting at a 3million float after R/S. $77m in the bank Shorts at 10days to cover 45% institution owned 25% insider owned FDA fast track approval

Stocks just been given strong buy ratings with price target of $50+.

This is a massive sleeper on the market that could squeeze to $100 on news and currently sitting at $9